Home Oncternal Therapeutics

Oncternal Therapeutics

In operation
Post-IPO Round
Cancer Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

Oncternal Therapeutics is a clinical-stage oncology company focused on developing therapies for various cancers with unmet medical needs. Oncternal concentrates its drug development efforts on promising but underexplored biological pathways associated with cancer progression.
Oncternal Therapeutics, Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2013
investor.relations@oncternal.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Therapeutic Products Lymphoma Prostate Cancer
Application Scenarios
Innovative Drugs